Literature DB >> 15538727

Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application.

C Rudolph1, A Ortiz, U Schillinger, J Jauernig, C Plank, J Rosenecker.   

Abstract

BACKGROUND: Polyethylenimine (PEI) has been successfully used for gene delivery to the lungs of mice via aerosol application using a whole body nebulization device. In this report we optimized the design of such an aerosol device.
METHODS: Aerosol devices were constructed as either serial inhalation apparatus or as a whole body nebulization chamber connected to an aerosol spacer placed in a horizontal or vertical position. PEI-based gene vectors were nebulized using a standard jet nebulizer and luciferase gene expression of various tissues was examined.
RESULTS: Using a whole body aerosol device resulted in luciferase gene expression in the lungs of mice at the same level as compared with a serial inhalation apparatus. Whereas gene expression was enhanced in the presence of 5% CO(2)-in-air, anesthesia of mice strongly decreased gene expression even when mice were intubated with an intravascular cannula. Reduction of the median mass aerodynamic diameter (MMAD) of the aerosol from 3.4 to 0.27 microm by interposition of an aerosol spacer increased gene expression significantly 3-fold. Drying of the aerosol by silica gel additionally increased gene delivery significantly 3-fold. Reporter gene expression mediated by branched PEI 25 kDa was 9- and 15-fold higher as compared with linear PEIs of 22 and 25 kDa, respectively, and was dependent on the DNA concentration. Gene expression was detectable as soon as 6 h after gene vector application and reached a maximum after 72 h but was still detectable after 14 days. The presence of Zn(2+) did not increase gene expression.
CONCLUSION: We propose aerosol drying as a novel and simple method of optimizing PEI-based gene delivery to the lungs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15538727     DOI: 10.1002/jgm.646

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  14 in total

1.  Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung.

Authors:  Guenther Hasenpusch; Johannes Geiger; Kai Wagner; Olga Mykhaylyk; Frank Wiekhorst; Lutz Trahms; Alexandra Heidsieck; Bernhard Gleich; Christian Bergemann; Manish K Aneja; Carsten Rudolph
Journal:  Pharm Res       Date:  2012-01-21       Impact factor: 4.200

2.  Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection.

Authors:  Young-Wook Won; Hyun Ah Kim; Minhyung Lee; Yong-Hee Kim
Journal:  Mol Ther       Date:  2009-12-22       Impact factor: 11.454

3.  Interaction of poly(ethylenimine)-DNA polyplexes with mitochondria: implications for a mechanism of cytotoxicity.

Authors:  Giovanna Grandinetti; Nilesh P Ingle; Theresa M Reineke
Journal:  Mol Pharm       Date:  2011-07-18       Impact factor: 4.939

4.  Aerosol gene delivery to the murine lung is mouse strain dependent.

Authors:  Petra Dames; Aurora Ortiz; Ulrike Schillinger; Eugenia Lesina; Christian Plank; Joseph Rosenecker; Carsten Rudolph
Journal:  J Mol Med (Berl)       Date:  2006-12-08       Impact factor: 4.599

5.  Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.

Authors:  Melissa P Lokugamage; Daryll Vanover; Jared Beyersdorf; Marine Z C Hatit; Laura Rotolo; Elisa Schrader Echeverri; Hannah E Peck; Huanzhen Ni; Jeong-Kee Yoon; YongTae Kim; Philip J Santangelo; James E Dahlman
Journal:  Nat Biomed Eng       Date:  2021-10-06       Impact factor: 25.671

6.  REV1 is implicated in the development of carcinogen-induced lung cancer.

Authors:  Chad A Dumstorf; Suparna Mukhopadhyay; Elangovan Krishnan; Bodduluri Haribabu; W Glenn McGregor
Journal:  Mol Cancer Res       Date:  2009-01-27       Impact factor: 5.852

7.  In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging.

Authors:  Kvar C L Black; Aida Ibricevic; Sean P Gunsten; Jeniree A Flores; Tiffany P Gustafson; Jeffery E Raymond; Sandani Samarajeewa; Ritu Shrestha; Simcha E Felder; Tianyi Cai; Yuefei Shen; Ann-Kathrin Löbs; Natalia Zhegalova; Deborah H Sultan; Mikhail Berezin; Karen L Wooley; Yongjian Liu; Steven L Brody
Journal:  Biomaterials       Date:  2016-05-03       Impact factor: 15.304

8.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

9.  Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.

Authors:  Frank Wegmann; Kate H Gartlan; Ali M Harandi; Sarah A Brinckmann; Margherita Coccia; William R Hillson; Wai Ling Kok; Suzanne Cole; Ling-Pei Ho; Teresa Lambe; Manoj Puthia; Catharina Svanborg; Erin M Scherer; George Krashias; Adam Williams; Joseph N Blattman; Philip D Greenberg; Richard A Flavell; Amin E Moghaddam; Neil C Sheppard; Quentin J Sattentau
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908

Review 10.  Vectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.

Authors:  Paul Zarogouldis; Nikos K Karamanos; Konstantinos Porpodis; Kalliopi Domvri; Haidong Huang; Wolfgang Hohenforst-Schimdt; Eugene P Goldberg; Konstantinos Zarogoulidis
Journal:  Int J Mol Sci       Date:  2012-08-29       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.